Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;38(1):129-143.
doi: 10.1007/s10875-017-0465-8. Epub 2017 Dec 11.

The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies

Affiliations

The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies

Aziz Bousfiha et al. J Clin Immunol. 2018 Jan.

Abstract

Since the 1990s, the International Union of Immunological Societies (IUIS) PID expert committee (EC), now called Inborn Errors of Immunity Committee, has published every other year a classification of the inborn errors of immunity. This complete catalog serves as a reference for immunologists and researchers worldwide. However, it was unadapted for clinicians at the bedside. For those, the IUIS PID EC is now publishing a phenotypical classification since 2013, which proved to be more user-friendly. There are now 320 single-gene inborn errors of immunity underlying phenotypes as diverse as infection, malignancy, allergy, auto-immunity, and auto-inflammation. We herein propose the revised 2017 phenotypic classification, based on the accompanying 2017 IUIS Inborn Errors of Immunity Committee classification.

Keywords: Classification; IUIS; Inborn errors of immunity; Phenotypic; Primary immunodeficiencies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Immunodeficiencies affecting cellular and humoral immunity. a Severe combined immunodeficiencies defined by T cell lymphopenia. b Combined immunodeficiencies. * T cell lymphopenia in SCID is defined by CD3+ T cells < 300/µL. AD: autosomal dominant transmission; ADA: adenosine deaminase; Ag: antigen; AR: autosomal recessive transmission; β2m: bêta-2 microglobulin; Bc: B cells; CBC: complete blood count; CD: cluster of differentiation; CVID: common variable immunodeficiency; def: deficiency; EBV: Epstein Barr virus; HHV8: human herpes virus 8; HIGM: hyper IgM syndrome; HPV: human papillomavirus; Ig: immunoglobulins; MHC: major histocompatibility complex; Nl: normal; NK: natural killer; SCID: severe combined immunodeficiency; Tc: T cells; TCR: T cell receptor; Treg: regulatory T cells; XL: X-linked transmission
Fig. 2
Fig. 2
a, b CID with associated or syndromic features. Ab: antibody; AD: autosomal dominant transmission; ANA: anti-nuclear antibodies; ANCA: anti-neutrophil cytoplasm antibodies; AR: autosomal recessive transmission; Bc: B cells; BCG: Bacillus Calmette-Guerin; BCR: B cell receptor; CD: cluster of differentiation; CMV: cytomegalovirus; CNS: central nervous system; def: deficiency; DNA: desoxyribonucleic acid; DKC: dyskeratosis congenita; EDA: anhidrotic ectodermal dysplasia; GOF: gain-of-function; HIES: hyper IgE syndrome; FILS: facial dysmorphism, immunodeficiency, livedo and short stature; ID: immunodeficiency; Ig: immunoglobulins; IUGR: intrauterine growth retardation; LOF: loss-of-function; MDS: myelodysplasia; Nl: normal; NK: natural killer; PHA: phytohemagglutinin; PPS: polysaccharides; SCID: severe combined immunodeficiency; sd: syndrome; Tc: T cells; TCR: T cell receptor; TREC: T cell receptor excision circle; XL: X-linked transmission
Fig. 2
Fig. 2
a, b CID with associated or syndromic features. Ab: antibody; AD: autosomal dominant transmission; ANA: anti-nuclear antibodies; ANCA: anti-neutrophil cytoplasm antibodies; AR: autosomal recessive transmission; Bc: B cells; BCG: Bacillus Calmette-Guerin; BCR: B cell receptor; CD: cluster of differentiation; CMV: cytomegalovirus; CNS: central nervous system; def: deficiency; DNA: desoxyribonucleic acid; DKC: dyskeratosis congenita; EDA: anhidrotic ectodermal dysplasia; GOF: gain-of-function; HIES: hyper IgE syndrome; FILS: facial dysmorphism, immunodeficiency, livedo and short stature; ID: immunodeficiency; Ig: immunoglobulins; IUGR: intrauterine growth retardation; LOF: loss-of-function; MDS: myelodysplasia; Nl: normal; NK: natural killer; PHA: phytohemagglutinin; PPS: polysaccharides; SCID: severe combined immunodeficiency; sd: syndrome; Tc: T cells; TCR: T cell receptor; TREC: T cell receptor excision circle; XL: X-linked transmission
Fig. 3
Fig. 3
Predominantly antibody deficiencies. a Hypogammaglobulinemias. b Other antibody deficiencies. AD: autosomal dominant transmission; AR: autosomal recessive transmission; Bc: B cells; BENTA: B cell expansion with NF-κB and T cell anergy; CD: cluster of differentiation; CMF: flow cytometry; COPD: chronic obstructive pulmonary disease; def: deficiency; EBV: Epstein Barr virus; GOF: gain-of-function; Hx: patient history; Ig: immunoglobulins; Nl: normal; XL: X-linked transmission
Fig. 4
Fig. 4
Diseases of immune dysregulation. a Hemophagocytic lymphohistiocytosis. b Other diseases of immune dysregulation. Ab: antibody; AD: autosomal dominant transmission; Ag: antigen; ALPS: autoimmune lymphoproliferative syndrome; APS: autoimmune polyendocrinopathy syndrome; AR: autosomal recessive transmission; Bc: B cells; CD: cluster of differentiation; CMF: flow cytometry; CTL: cytotoxic T lymphocytes; def: deficiency; DNT: double negative T cells; EBV: Epstein Barr virus; FHL: familial hemophagocytic lymphohistiocytosis; GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis; (H)SM: (hepato)splenomegalia; IBD: inflammatory bowel disease; Ig: immunoglobulin; IL-10: interleukin-10; LOF: loss-of-function; iNKT: invariant NKT cells; NK: natural killer cells; Nl: normal; sd: syndrome; SLE: systemic lupus erythematous disease; Tc: T cells; TCR: T cell receptor; XL: X-linked transmission
Fig. 4
Fig. 4
Diseases of immune dysregulation. a Hemophagocytic lymphohistiocytosis. b Other diseases of immune dysregulation. Ab: antibody; AD: autosomal dominant transmission; Ag: antigen; ALPS: autoimmune lymphoproliferative syndrome; APS: autoimmune polyendocrinopathy syndrome; AR: autosomal recessive transmission; Bc: B cells; CD: cluster of differentiation; CMF: flow cytometry; CTL: cytotoxic T lymphocytes; def: deficiency; DNT: double negative T cells; EBV: Epstein Barr virus; FHL: familial hemophagocytic lymphohistiocytosis; GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis; (H)SM: (hepato)splenomegalia; IBD: inflammatory bowel disease; Ig: immunoglobulin; IL-10: interleukin-10; LOF: loss-of-function; iNKT: invariant NKT cells; NK: natural killer cells; Nl: normal; sd: syndrome; SLE: systemic lupus erythematous disease; Tc: T cells; TCR: T cell receptor; XL: X-linked transmission
None
Congenital defects of phagocyte number, function, or both. a Neutropenia. b Functional defects of phagocytes. AD: autosomal dominant transmission; AML: acute myeloid leukemia; AR: autosomal recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of differentiation; CGD: chronic granulomatous disease; CMF: flow cytometry; CMML: chronic myelomonocytic leukemia; def: deficiency; DHR: dihydrorhodamine-1,2,3; GOF: gain-of-function; IUGR: intrauterine growth retardation; MDS: myelodysplasia; NBT: nitroblue of tetrazolium; NK: natural killer cells; WBC: white blood cells; XL: X-linked transmission
Fig. 6
Fig. 6
Defects in intrinsic and innate immunity. a Bacterial and parasitic infections. b MSMD and viral infection. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of differentiation; CMC: chronic mucocutaneous candidiasis; GOF: gain-of-function; IFNg: interferon-gamma; HHV6: human herpes virus type 6; HPV: human papilloma virus; HSV: herpes simplex virus; LOF: loss-of-function; MSMD: Mendelian susceptibility to mycobacterial disease; NK: natural killer cells; RNA: ribonucleic acid; sd: syndrome; Tc: T cells; TLR3: Toll-like receptor type 3; VZV: varicella zoster virus; XL: X-linked transmission
Fig. 6
Fig. 6
Defects in intrinsic and innate immunity. a Bacterial and parasitic infections. b MSMD and viral infection. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of differentiation; CMC: chronic mucocutaneous candidiasis; GOF: gain-of-function; IFNg: interferon-gamma; HHV6: human herpes virus type 6; HPV: human papilloma virus; HSV: herpes simplex virus; LOF: loss-of-function; MSMD: Mendelian susceptibility to mycobacterial disease; NK: natural killer cells; RNA: ribonucleic acid; sd: syndrome; Tc: T cells; TLR3: Toll-like receptor type 3; VZV: varicella zoster virus; XL: X-linked transmission
Fig. 7
Fig. 7
a, b Autoinflammatory disorders. *Diseases affecting the inflammasome. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BSN: bilateral striatal necrosis; CAPS: cryopirin-associated periodic syndrome; DA: duration of inflammation episode; FA: frequency of inflammation episode; FCL: familial chilblain lupus; GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis; HSM: hepatosplenomegalia; ICC: intracranial calcifications; IL: interleukin; LOF: loss-of-function; sd: syndrome; SLE: systemic lupus erythematosus; SMS: Singleton-Merten syndrome; SNHL: sensorineural hearing loss; SP: spastic paraparesis; TORCH: toxoplasmosis, other, rubella, cytomegalovirus, and herpes infections
Fig. 7
Fig. 7
a, b Autoinflammatory disorders. *Diseases affecting the inflammasome. AD: autosomal dominant transmission; AR: autosomal recessive transmission; BSN: bilateral striatal necrosis; CAPS: cryopirin-associated periodic syndrome; DA: duration of inflammation episode; FA: frequency of inflammation episode; FCL: familial chilblain lupus; GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis; HSM: hepatosplenomegalia; ICC: intracranial calcifications; IL: interleukin; LOF: loss-of-function; sd: syndrome; SLE: systemic lupus erythematosus; SMS: Singleton-Merten syndrome; SNHL: sensorineural hearing loss; SP: spastic paraparesis; TORCH: toxoplasmosis, other, rubella, cytomegalovirus, and herpes infections
Fig. 8
Fig. 8
Complement deficiencies. AD: autosomal dominant transmission; AH50: alternate pathway hemolytic activity; AR: autosomal recessive transmission; CH50: complement hemolytic activity; def: deficiency; LOF: loss-of-function; sd: syndrome; SLE: systemic lupus erythematosus; XL: X-linked transmission
Fig. 9
Fig. 9
Phenocopies of PID. ALPS: autoimmune lymphoproliferative syndrome; AutoAb: auto-antibodies; CID: combined immunodeficiency; CMC: chronic mucocutaneous candidiasis; GOF: gain-of-function; MSMD: Mendelian susceptibility to mycobacterial disease; PRCA: pure red cell aplasia

Similar articles

Cited by

References

    1. Picard C, Gaspar HB, Al-Herz W, Bousfiha A, Chatila T, Crow YJ, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity. J Clin Immunol 2017(in Press). - PMC - PubMed
    1. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, Abel L. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7. doi: 10.1007/s10875-012-9751-7. - DOI - PubMed
    1. Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014;34(8):954–961. doi: 10.1007/s10875-014-0102-8. - DOI - PMC - PubMed
    1. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–1087. doi: 10.1007/s10875-013-9901-6. - DOI - PMC - PubMed
    1. Jeddane L, Ouair H, Benhsaien I, El Bakkouri J, Bousfiha AA. Primary immunodeficiency classification on smartphone. J Clin Immunol. 2017;37(1):1–2. doi: 10.1007/s10875-016-0354-6. - DOI - PubMed